About us
Business overview
Our locations
Our story
Regenerative medicine
Business model
Our technology
Our strategy
Sustainability
Board of Directors
Our team
BioSurgery
Overview
DermaPure
®
DermaPure
®
overview
DermaPure
®
IFU
Customer service
Orthopaedics
Overview
OrthoPure
®
XT
OrthoPure® XT overview
OrthoPure® evidence & education
Information for patients
ConCelltrate
®
100
MatrixCellect
Matrix IQ
®
Dermis
Matrix OI
Matrix OI® FlexIt
Matrix OI® 100 DBM Cortical fibres and fillers
Matrix OI® Strips and Blocks
Sports medicine grafts
Conventional grafts
Amnioworks
Dental
Overview
MatrixCellect
DentalFix™
Matrix IQ
®
Dermis
Matrix OI
Matrix OI® FlexIt
Matrix OI® 100 DBM Cortical fibres and fillers
Matrix OI® Strips and Blocks
Investors
Investment case
Share price chart
Results, reports and presentations
RNS
Corporate governance
Corporate Governance Statement
Audit committee
Remuneration committee
Shareholder centre
Advisors and shareholders
Calendar
Research notes
AGM information
AIM rules
Risks
Offer Period Information
Media
RNS
Video
Contact us
Please use the arrows to navigate to the sub pages
Investors
Investment case
Share price chart
Results, reports and presentations
RNS
Corporate governance
Corporate Governance Statement
Audit committee
Remuneration committee
Shareholder centre
Advisors and shareholders
Calendar
Research notes
AGM information
AIM rules
Risks
Offer Period Information
Media
RNS
Video
Contact us
About us
Business overview
Our locations
Our story
Regenerative medicine
Business model
Our technology
Our strategy
Sustainability
Board of Directors
Our team
Our technology
BioSurgery
Overview
DermaPure
®
DermaPure
®
overview
DermaPure
®
IFU
Customer service
Orthopaedics
Overview
OrthoPure
®
XT
OrthoPure® XT overview
OrthoPure® evidence & education
Information for patients
ConCelltrate
®
100
MatrixCellect
Matrix IQ
®
Dermis
Matrix OI
Matrix OI® FlexIt
Matrix OI® 100 DBM Cortical fibres and fillers
Matrix OI® Strips and Blocks
Sports medicine grafts
Conventional grafts
Amnioworks
Overview
Dental
Overview
MatrixCellect
DentalFix™
Matrix IQ
®
Dermis
Matrix OI
Matrix OI® FlexIt
Matrix OI® 100 DBM Cortical fibres and fillers
Matrix OI® Strips and Blocks
Overview
Search
RNS
Investors
Home
Investors
RNS
RNS filters
Search
Go
Date range
Categories
Acquisition [ACQ]
AGM Statement [AGM]
Agreement [AGR]
Second Price Monitoring Extn [APM]
Change of Advisor [APP]
Directorate change [BOA]
Contract [CNT]
Change of Registered Office [CRO]
Director/PDMR Shareholding [DSH]
Form 8 (OPD) [FEE]
Final Results [FR]
Holding(s) in Company [HOL]
Issue of Equity [IOE]
Half-year Report [IR]
Miscellaneous [MSC]
Notice of AGM [NOA]
Notice of GM [NOG]
Notice of Results [NOR]
Non-Regulatory Announcement [NRA]
Price Monitoring Extension [PME]
Product Launch [PRL]
Result of AGM [RAG]
Director Declaration [RDN]
Research Update [RES]
Result of Equity Issue [ROI]
Result of Meeting [ROM]
Trading Statement [TST]
Total Voting Rights [TVR]
Strategy/Company/Operations Update [UPD]
Reset filters
Lombard Odier - Form 8.3 - Tissue Regenix Group PLC
N/A
16 December 2024 02:31
16 12 2024 02:31
Lombard Odier - Form 8.3 - Tissue Regenix Group PLC
Cavendish Securities - Form 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC
N/A
16 December 2024 08:58
16 12 2024 08:58
Cavendish Securities - Form 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
13 December 2024 11:08
13 12 2024 11:08
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
12 December 2024 10:19
12 12 2024 10:19
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
11 December 2024 11:16
11 12 2024 11:16
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Lombard Odier - Form 8.3 - Tissue Regenix Group PLC
N/A
10 December 2024 12:15
10 12 2024 12:15
Lombard Odier - Form 8.3 - Tissue Regenix Group PLC
Lexham Special Opps - Form 8.3 - Tissue Regenix Group plc
N/A
09 December 2024 05:52
09 12 2024 05:52
Lexham Special Opps - Form 8.3 - Tissue Regenix Group plc
Holding(s) in Company
HOL
09 December 2024 02:44
09 12 2024 02:44
Holding(s) in Company
Lombard Odier - Form 8.3 - Tissue Regenix Group PLC
N/A
09 December 2024 11:35
09 12 2024 11:35
Lombard Odier - Form 8.3 - Tissue Regenix Group PLC
IP Group PLC - Form 8.3 - Tissue Regenix Group plc
N/A
06 December 2024 01:57
06 12 2024 01:57
IP Group PLC - Form 8.3 - Tissue Regenix Group plc
Lombard Odier - Form 8.3 - Tissue Regenix Group PLC
N/A
05 December 2024 12:04
05 12 2024 12:04
Lombard Odier - Form 8.3 - Tissue Regenix Group PLC
Extended distribution agreement with Arthrex, Inc.
AGR
26 November 2024 07:00
26 11 2024 07:00
Extended distribution agreement with Arthrex, Inc.
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
25 November 2024 09:30
25 11 2024 09:30
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
22 November 2024 09:16
22 11 2024 09:16
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
21 November 2024 09:22
21 11 2024 09:22
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Holding(s) in Company
HOL
20 November 2024 02:07
20 11 2024 02:07
Holding(s) in Company
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
20 November 2024 11:16
20 11 2024 11:16
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Charles Stanley & Co - Form 8.3 - Tissue Regenix Group plc
N/A
20 November 2024 11:12
20 11 2024 11:12
Charles Stanley & Co - Form 8.3 - Tissue Regenix Group plc
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
19 November 2024 08:38
19 11 2024 08:38
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Harwood Capital Mgmt - Form 8.3 - Tissue Regenix Group PLC
N/A
18 November 2024 12:43
18 11 2024 12:43
Harwood Capital Mgmt - Form 8.3 - Tissue Regenix Group PLC
IP Group PLC - Form 8.3 - Tissue Regenix Group plc
N/A
15 November 2024 08:45
15 11 2024 08:45
IP Group PLC - Form 8.3 - Tissue Regenix Group plc
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
14 November 2024 09:19
14 11 2024 09:19
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Richard Griffiths - Form 8.3 - Tissue Regenix Group Plc
N/A
13 November 2024 09:32
13 11 2024 09:32
Richard Griffiths - Form 8.3 - Tissue Regenix Group Plc
Form 8 (OPD) (Tissue Regenix Group Plc)
FEE
12 November 2024 04:05
12 11 2024 04:05
Form 8 (OPD) (Tissue Regenix Group Plc)
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
12 November 2024 08:46
12 11 2024 08:46
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
11 November 2024 09:17
11 11 2024 09:17
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Cavendish Securities - Form 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC
N/A
07 November 2024 09:59
07 11 2024 09:59
Cavendish Securities - Form 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC
Lombard Odier - Form 8.3 - Tissue Regenix Group PLC
N/A
06 November 2024 01:37
06 11 2024 01:37
Lombard Odier - Form 8.3 - Tissue Regenix Group PLC
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
06 November 2024 08:52
06 11 2024 08:52
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Form 8.3 - Tissue Regenix Group PLC
N/A
05 November 2024 02:24
05 11 2024 02:24
Form 8.3 - Tissue Regenix Group PLC
Cavendish Securities - Form 8.5 (EPT/NON-RI)
N/A
05 November 2024 11:32
05 11 2024 11:32
Cavendish Securities - Form 8.5 (EPT/NON-RI)
Response to media speculation
N/A
04 November 2024 04:36
04 11 2024 04:36
Response to media speculation
Interim results for the six months ended 30 June
IR
10 September 2024 07:00
10 09 2024 07:00
Interim results for the six months ended 30 June
Confirmation of results
NRA
21 August 2024 07:00
21 08 2024 07:00
Confirmation of results
Grant of share options
DSH
18 July 2024 03:52
18 07 2024 03:52
Grant of share options
Half-Year Trading Update
TST
16 July 2024 07:00
16 07 2024 07:00
Half-Year Trading Update
Holding(s) in Company
HOL
03 July 2024 01:16
03 07 2024 01:16
Holding(s) in Company
Holding(s) in Company
HOL
24 June 2024 04:12
24 06 2024 04:12
Holding(s) in Company
Exercise of Options, Director Dealing and TVR
DSH
18 June 2024 05:15
18 06 2024 05:15
Exercise of Options, Director Dealing and TVR
Building purchase
MSC
14 June 2024 07:00
14 06 2024 07:00
Building purchase
Result of AGM
RAG
25 April 2024 02:27
25 04 2024 02:27
Result of AGM
Holding(s) in Company
HOL
05 April 2024 03:52
05 04 2024 03:52
Holding(s) in Company
Final results for the year ended 31 December 2023
FR
19 March 2024 07:00
19 03 2024 07:00
Final results for the year ended 31 December 2023
Notice of Results
NOR
01 March 2024 07:00
01 03 2024 07:00
Notice of Results
First EU shipment & new distributor agreements
NRA
06 February 2024 07:00
06 02 2024 07:00
First EU shipment & new distributor agreements
Holding(s) in Company
HOL
29 January 2024 03:02
29 01 2024 03:02
Holding(s) in Company
Trading update for 2023
TST
25 January 2024 07:00
25 01 2024 07:00
Trading update for 2023
2023 LTIP Grant
DSH
23 January 2024 05:24
23 01 2024 05:24
2023 LTIP Grant
Holding(s) in Company
HOL
22 November 2023 04:36
22 11 2023 04:36
Holding(s) in Company
HPRA approval & distribution agreement in Spain
MSC
30 October 2023 07:00
30 10 2023 07:00
HPRA approval & distribution agreement in Spain
Director/PDMR Shareholding
DSH
15 September 2023 04:30
15 09 2023 04:30
Director/PDMR Shareholding
New sports medicine product launch
PRL
05 September 2023 07:01
05 09 2023 07:01
New sports medicine product launch
Interim results
IR
05 September 2023 07:00
05 09 2023 07:00
Interim results
Exercise of Options and Total Voting Rights
IOE
31 August 2023 01:45
31 08 2023 01:45
Exercise of Options and Total Voting Rights
Notice of interim results
NOR
21 August 2023 07:00
21 08 2023 07:00
Notice of interim results
Half-Year Trading Update
TST
17 July 2023 07:00
17 07 2023 07:00
Half-Year Trading Update
Distribution agreement for OrthoPure® XT in the UK
AGR
10 July 2023 07:00
10 07 2023 07:00
Distribution agreement for OrthoPure® XT in the UK
Distribution agreement with Australian Allografts
AGR
25 May 2023 07:00
25 05 2023 07:00
Distribution agreement with Australian Allografts
Holding(s) in Company
HOL
09 May 2023 12:00
09 05 2023 12:00
Holding(s) in Company
Result of AGM, Share Reorganisation &TVR
RAG
27 April 2023 12:35
27 04 2023 12:35
Result of AGM, Share Reorganisation &TVR
Proposed Share Reorganisation Timetable
MSC
18 April 2023 07:00
18 04 2023 07:00
Proposed Share Reorganisation Timetable
CEO and CFO Share Purchases
DSH
05 April 2023 07:00
05 04 2023 07:00
CEO and CFO Share Purchases
Holding(s) in Company
HOL
30 March 2023 07:00
30 03 2023 07:00
Holding(s) in Company
Final results for the year ended 31 December 2022
FR
21 March 2023 07:00
21 03 2023 07:00
Final results for the year ended 31 December 2022
Notice of results and Investor presentation
NOR
06 March 2023 07:00
06 03 2023 07:00
Notice of results and Investor presentation
Trading update for 2022
TST
31 January 2023 07:01
31 01 2023 07:01
Trading update for 2022
Change of Adviser
APP
31 January 2023 07:00
31 01 2023 07:00
Change of Adviser
Holding(s) in Company
HOL
18 January 2023 10:06
18 01 2023 10:06
Holding(s) in Company
Chinese distribution agreement for OrthoPure® XT
AGR
18 January 2023 07:00
18 01 2023 07:00
Chinese distribution agreement for OrthoPure® XT
Product launch in dCELL® division
PRL
07 December 2022 07:00
07 12 2022 07:00
Product launch in dCELL® division
Distribution agreement - OrthoPure® XT in Germany
MSC
22 November 2022 07:00
22 11 2022 07:00
Distribution agreement - OrthoPure® XT in Germany
Holding(s) in Company
HOL
14 November 2022 06:05
14 11 2022 06:05
Holding(s) in Company
Holding(s) in Company
HOL
07 November 2022 02:35
07 11 2022 02:35
Holding(s) in Company
Director/PDMR Shareholding
DSH
29 September 2022 10:13
29 09 2022 10:13
Director/PDMR Shareholding
Half-year Report
IR
07 September 2022 07:00
07 09 2022 07:00
Half-year Report
Holding(s) in Company
HOL
22 August 2022 03:31
22 08 2022 03:31
Holding(s) in Company
Holding(s) in Company
HOL
18 August 2022 05:36
18 08 2022 05:36
Holding(s) in Company
Holding(s) in Company
HOL
18 August 2022 02:10
18 08 2022 02:10
Holding(s) in Company
Holding(s) in Company
HOL
11 August 2022 12:46
11 08 2022 12:46
Holding(s) in Company
Holding(s) in Company
HOL
11 August 2022 12:17
11 08 2022 12:17
Holding(s) in Company
Confirmation of Interim Results
NOR
11 August 2022 07:00
11 08 2022 07:00
Confirmation of Interim Results
Holding(s) in Company
HOL
05 August 2022 03:19
05 08 2022 03:19
Holding(s) in Company
Holding(s) in Company
HOL
01 August 2022 03:14
01 08 2022 03:14
Holding(s) in Company
Half Year Trading Update and Notice of Results
TST
19 July 2022 07:00
19 07 2022 07:00
Half Year Trading Update and Notice of Results
Holding(s) in Company
HOL
18 July 2022 02:42
18 07 2022 02:42
Holding(s) in Company
Holding(s) in Company
HOL
18 July 2022 01:33
18 07 2022 01:33
Holding(s) in Company
Holding(s) in Company
HOL
15 July 2022 05:29
15 07 2022 05:29
Holding(s) in Company
Holding(s) in Company
HOL
27 June 2022 06:04
27 06 2022 06:04
Holding(s) in Company
Holding(s) in Company
HOL
27 June 2022 12:58
27 06 2022 12:58
Holding(s) in Company
Exercise of Options and Total Voting Rights
TVR
16 June 2022 01:27
16 06 2022 01:27
Exercise of Options and Total Voting Rights
OrthoPure®XT clinical results presentation
NRA
28 April 2022 07:00
28 04 2022 07:00
OrthoPure®XT clinical results presentation
Result of AGM
RAG
26 April 2022 04:19
26 04 2022 04:19
Result of AGM
Director/PDMR Shareholding
DSH
20 April 2022 04:26
20 04 2022 04:26
Director/PDMR Shareholding
Grant of share options
DSH
08 April 2022 07:00
08 04 2022 07:00
Grant of share options
Director/PDMR Shareholding
DSH
06 April 2022 02:59
06 04 2022 02:59
Director/PDMR Shareholding
Final year results for the year ended 31 Dec 2021
FR
15 March 2022 07:00
15 03 2022 07:00
Final year results for the year ended 31 Dec 2021
Distribution agreement for OrthoPure® XT
AGR
09 March 2022 07:00
09 03 2022 07:00
Distribution agreement for OrthoPure® XT
Notice of Results
NOR
02 March 2022 07:00
02 03 2022 07:00
Notice of Results
Additional Director Disclosures
RDN
10 February 2022 03:45
10 02 2022 03:45
Additional Director Disclosures
Full Year Trading update
TST
27 January 2022 07:00
27 01 2022 07:00
Full Year Trading update
Director/PDMR Shareholding
DSH
23 December 2021 07:00
23 12 2021 07:00
Director/PDMR Shareholding
Second Price Monitoring Extn
APM
21 December 2021 02:06
21 12 2021 02:06
Second Price Monitoring Extn
Price Monitoring Extension
PME
21 December 2021 02:01
21 12 2021 02:01
Price Monitoring Extension
Holding(s) in Company
HOL
08 October 2021 07:00
08 10 2021 07:00
Holding(s) in Company
Holding(s) in Company
HOL
05 October 2021 04:44
05 10 2021 04:44
Holding(s) in Company
Holding(s) in Company
HOL
28 September 2021 07:00
28 09 2021 07:00
Holding(s) in Company
Director/PDMR Shareholding
DSH
24 September 2021 02:05
24 09 2021 02:05
Director/PDMR Shareholding
Director/PDMR Shareholding
DSH
09 September 2021 04:35
09 09 2021 04:35
Director/PDMR Shareholding
Half-year Report
IR
08 September 2021 07:00
08 09 2021 07:00
Half-year Report
Notice of Results
NOR
01 September 2021 07:00
01 09 2021 07:00
Notice of Results
Launch of DermaPure® Meshed and VNEWTM
NRA
01 September 2021 07:00
01 09 2021 07:00
Launch of DermaPure® Meshed and VNEWTM
Holding(s) in Company
HOL
16 August 2021 07:00
16 08 2021 07:00
Holding(s) in Company
Director/PDMR Shareholding
DSH
29 June 2021 01:00
29 06 2021 01:00
Director/PDMR Shareholding
Completion of phase 1 of new US facility expansion
NRA
28 June 2021 07:00
28 06 2021 07:00
Completion of phase 1 of new US facility expansion
Director/PDMR Shareholding
DSH
23 June 2021 06:08
23 06 2021 06:08
Director/PDMR Shareholding
Holding(s) in Company
HOL
10 June 2021 04:17
10 06 2021 04:17
Holding(s) in Company
Result of AGM
RAG
03 June 2021 01:37
03 06 2021 01:37
Result of AGM
Director/PDMR Shareholding
DSH
11 May 2021 07:00
11 05 2021 07:00
Director/PDMR Shareholding
Director/PDMR Shareholding
DSH
10 May 2021 10:00
10 05 2021 10:00
Director/PDMR Shareholding
Grant of share options
DSH
05 May 2021 07:00
05 05 2021 07:00
Grant of share options
Holding(s) in Company
HOL
29 April 2021 04:11
29 04 2021 04:11
Holding(s) in Company
Final Results and Notice of AGM
FR
28 April 2021 07:00
28 04 2021 07:00
Final Results and Notice of AGM
Holding(s) in Company
HOL
20 April 2021 01:07
20 04 2021 01:07
Holding(s) in Company
Holding(s) in Company
HOL
20 April 2021 12:10
20 04 2021 12:10
Holding(s) in Company
Notice of Results
NOR
19 April 2021 07:00
19 04 2021 07:00
Notice of Results
Holding(s) in Company
HOL
13 April 2021 07:00
13 04 2021 07:00
Holding(s) in Company
Second Price Monitoring Extn
APM
01 April 2021 04:40
01 04 2021 04:40
Second Price Monitoring Extn
Price Monitoring Extension
PME
01 April 2021 04:36
01 04 2021 04:36
Price Monitoring Extension
Initial phase of US facility expansion complete
MSC
18 March 2021 07:00
18 03 2021 07:00
Initial phase of US facility expansion complete
Directorate Change
BOA
26 February 2021 07:00
26 02 2021 07:00
Directorate Change
Holding(s) in Company
HOL
19 February 2021 03:52
19 02 2021 03:52
Holding(s) in Company
Move to Electronic Reporting
MSC
11 February 2021 07:00
11 02 2021 07:00
Move to Electronic Reporting
Trading Update
TST
08 February 2021 07:00
08 02 2021 07:00
Trading Update
Second Price Monitoring Extn
APM
05 February 2021 04:40
05 02 2021 04:40
Second Price Monitoring Extn
Price Monitoring Extension
PME
05 February 2021 04:35
05 02 2021 04:35
Price Monitoring Extension
Appointment of Chief Financial Officer
BOA
21 January 2021 07:00
21 01 2021 07:00
Appointment of Chief Financial Officer
PDMR Dealings
DSH
06 January 2021 03:58
06 01 2021 03:58
PDMR Dealings
Confirmation of Board appointments
BOA
05 January 2021 07:00
05 01 2021 07:00
Confirmation of Board appointments
Holdings in Company
HOL
04 January 2021 11:26
04 01 2021 11:26
Holdings in Company
Issue of Equity & Total Voting Rights Replacement
IOE
24 December 2020 12:56
24 12 2020 12:56
Issue of Equity & Total Voting Rights Replacement
Holdings in Company
HOL
24 December 2020 11:15
24 12 2020 11:15
Holdings in Company
Issue of Equity and Total Voting Rights
IOE
23 December 2020 09:51
23 12 2020 09:51
Issue of Equity and Total Voting Rights
Board Changes
BOA
04 December 2020 07:00
04 12 2020 07:00
Board Changes
Holdings in Company
HOL
03 December 2020 04:54
03 12 2020 04:54
Holdings in Company
First delivery of OrthoPure® XT
UPD
02 December 2020 07:00
02 12 2020 07:00
First delivery of OrthoPure® XT
Holdings in Company
HOL
27 November 2020 09:09
27 11 2020 09:09
Holdings in Company
Holdings in Company
HOL
26 November 2020 04:02
26 11 2020 04:02
Holdings in Company
Appointment of CEO
BOA
17 November 2020 07:00
17 11 2020 07:00
Appointment of CEO
Holdings in Company
HOL
06 November 2020 07:00
06 11 2020 07:00
Holdings in Company
Holdings in Company
HOL
29 October 2020 07:00
29 10 2020 07:00
Holdings in Company
Holdings in Company
HOL
29 October 2020 07:00
29 10 2020 07:00
Holdings in Company
Holdings in Company
HOL
26 October 2020 04:50
26 10 2020 04:50
Holdings in Company
Holdings in Company
HOL
28 September 2020 12:24
28 09 2020 12:24
Holdings in Company
Holdings in Company
HOL
16 September 2020 07:42
16 09 2020 07:42
Holdings in Company
Second Price Monitoring Extn
APM
15 September 2020 04:40
15 09 2020 04:40
Second Price Monitoring Extn
Price Monitoring Extension
PME
15 September 2020 04:35
15 09 2020 04:35
Price Monitoring Extension
Holdings in Company
HOL
14 September 2020 05:33
14 09 2020 05:33
Holdings in Company
Unaudited Interim Results
IR
02 September 2020 07:00
02 09 2020 07:00
Unaudited Interim Results
Notice of Interim Results & Investor Presentation
NOR
27 August 2020 07:00
27 08 2020 07:00
Notice of Interim Results & Investor Presentation
UK distribution partner for OrthoPure® XT
CNT
24 August 2020 07:00
24 08 2020 07:00
UK distribution partner for OrthoPure® XT
Holdings in Company
HOL
18 August 2020 11:27
18 08 2020 11:27
Holdings in Company
Relocation of UK office and manufacturing facility
MSC
17 August 2020 07:00
17 08 2020 07:00
Relocation of UK office and manufacturing facility
Holdings in Company
HOL
27 July 2020 09:59
27 07 2020 09:59
Holdings in Company
Commencement of facility expansion plan
MSC
24 July 2020 07:00
24 07 2020 07:00
Commencement of facility expansion plan
Holdings in Company
HOL
23 July 2020 06:22
23 07 2020 06:22
Holdings in Company
Holdings in Company
HOL
17 July 2020 09:56
17 07 2020 09:56
Holdings in Company
Holdings in Company
HOL
10 July 2020 03:18
10 07 2020 03:18
Holdings in Company
Holdings in Company
HOL
06 July 2020 09:31
06 07 2020 09:31
Holdings in Company
Holdings in Company
HOL
03 July 2020 10:01
03 07 2020 10:01
Holdings in Company
Total Voting Rights
TVR
30 June 2020 04:44
30 06 2020 04:44
Total Voting Rights
Result of AGM
RAG
30 June 2020 10:42
30 06 2020 10:42
Result of AGM
Option Exercise and Total Voting Rights
DSH
23 June 2020 03:07
23 06 2020 03:07
Option Exercise and Total Voting Rights
Holdings in Company
HOL
17 June 2020 12:57
17 06 2020 12:57
Holdings in Company
Second Price Monitoring Extn
APM
15 June 2020 02:06
15 06 2020 02:06
Second Price Monitoring Extn
Price Monitoring Extension
PME
15 June 2020 02:00
15 06 2020 02:00
Price Monitoring Extension
Holdings in Company
HOL
15 June 2020 11:31
15 06 2020 11:31
Holdings in Company
Holdings in Company
HOL
11 June 2020 04:54
11 06 2020 04:54
Holdings in Company
Holdings in Company
HOL
11 June 2020 04:26
11 06 2020 04:26
Holdings in Company
Holdings in Company
HOL
11 June 2020 01:21
11 06 2020 01:21
Holdings in Company
Holdings in Company
HOL
11 June 2020 11:20
11 06 2020 11:20
Holdings in Company
Second Price Monitoring Extn
APM
11 June 2020 11:05
11 06 2020 11:05
Second Price Monitoring Extn
Price Monitoring Extension
PME
11 June 2020 11:00
11 06 2020 11:00
Price Monitoring Extension
Holdings in Company
HOL
10 June 2020 04:53
10 06 2020 04:53
Holdings in Company
Holdings in Company
HOL
10 June 2020 04:51
10 06 2020 04:51
Holdings in Company
Holdings in Company
HOL
10 June 2020 04:49
10 06 2020 04:49
Holdings in Company
Holdings in Company
HOL
10 June 2020 04:35
10 06 2020 04:35
Holdings in Company
Result of General Meeting and Total Voting Rights
ROM
09 June 2020 01:10
09 06 2020 01:10
Result of General Meeting and Total Voting Rights
Director subscriptions/PDMR dealing
DSH
05 June 2020 09:15
05 06 2020 09:15
Director subscriptions/PDMR dealing
Annual results for the year ended 31 December 2019
FR
05 June 2020 07:00
05 06 2020 07:00
Annual results for the year ended 31 December 2019
Second Price Monitoring Extn
APM
04 June 2020 04:41
04 06 2020 04:41
Second Price Monitoring Extn
Price Monitoring Extension
PME
04 June 2020 04:35
04 06 2020 04:35
Price Monitoring Extension
Second Price Monitoring Extn
APM
03 June 2020 02:05
03 06 2020 02:05
Second Price Monitoring Extn
Price Monitoring Extension
PME
03 June 2020 02:00
03 06 2020 02:00
Price Monitoring Extension
Second Price Monitoring Extn
APM
01 June 2020 09:05
01 06 2020 09:05
Second Price Monitoring Extn
Price Monitoring Extension
PME
01 June 2020 09:00
01 06 2020 09:00
Price Monitoring Extension
CE Mark awarded for OrthoPure XT
MSC
01 June 2020 07:00
01 06 2020 07:00
CE Mark awarded for OrthoPure XT
Second Price Monitoring Extn
APM
29 May 2020 11:05
29 05 2020 11:05
Second Price Monitoring Extn
Price Monitoring Extension
PME
29 May 2020 11:00
29 05 2020 11:00
Price Monitoring Extension
Second Price Monitoring Extn
APM
27 May 2020 04:41
27 05 2020 04:41
Second Price Monitoring Extn
Price Monitoring Extension
PME
27 May 2020 04:36
27 05 2020 04:36
Price Monitoring Extension
Publication of circular and notice of GM
NOG
26 May 2020 07:00
26 05 2020 07:00
Publication of circular and notice of GM
Price Monitoring Extension
PME
22 May 2020 02:00
22 05 2020 02:00
Price Monitoring Extension
Second Price Monitoring Extn
APM
22 May 2020 11:05
22 05 2020 11:05
Second Price Monitoring Extn
Price Monitoring Extension
PME
22 May 2020 11:00
22 05 2020 11:00
Price Monitoring Extension
Confirmation of successful fundraising
IOE
22 May 2020 07:00
22 05 2020 07:00
Confirmation of successful fundraising
PrimaryBid.com Offer
IOE
21 May 2020 04:47
21 05 2020 04:47
PrimaryBid.com Offer
Proposed Equity Fundraise
IOE
21 May 2020 04:43
21 05 2020 04:43
Proposed Equity Fundraise
New collaboration with leading healthcare company
CNT
11 May 2020 07:00
11 05 2020 07:00
New collaboration with leading healthcare company
Additional US government-backed loan secured
MSC
20 April 2020 07:00
20 04 2020 07:00
Additional US government-backed loan secured
US Government backed loan extends cash runway
TST
15 April 2020 07:00
15 04 2020 07:00
US Government backed loan extends cash runway
Second Price Monitoring Extn
APM
03 April 2020 04:41
03 04 2020 04:41
Second Price Monitoring Extn
Price Monitoring Extension
PME
03 April 2020 04:35
03 04 2020 04:35
Price Monitoring Extension
Update in relation to working capital position
UPD
30 March 2020 07:00
30 03 2020 07:00
Update in relation to working capital position
Directorate Change
BOA
20 March 2020 07:00
20 03 2020 07:00
Directorate Change
Resolution of Cyber Security Incident
MSC
04 February 2020 11:47
04 02 2020 11:47
Resolution of Cyber Security Incident
Notice of cyber security incident
MSC
28 January 2020 10:02
28 01 2020 10:02
Notice of cyber security incident
Trading Update
TST
22 January 2020 07:00
22 01 2020 07:00
Trading Update
Second Price Monitoring Extn
APM
14 January 2020 04:40
14 01 2020 04:40
Second Price Monitoring Extn
Price Monitoring Extension
PME
14 January 2020 04:35
14 01 2020 04:35
Price Monitoring Extension
Price Monitoring Extension
PME
21 November 2019 04:35
21 11 2019 04:35
Price Monitoring Extension
Directorate Change
BOA
18 November 2019 04:03
18 11 2019 04:03
Directorate Change
Holding(s) in Company
HOL
14 November 2019 04:00
14 11 2019 04:00
Holding(s) in Company
Updated loan facility agreement with MidCap
UPD
14 November 2019 07:00
14 11 2019 07:00
Updated loan facility agreement with MidCap
Holding(s) in Company
HOL
13 November 2019 03:35
13 11 2019 03:35
Holding(s) in Company
Holding(s) in Company
HOL
13 November 2019 03:17
13 11 2019 03:17
Holding(s) in Company
Second Price Monitoring Extn
APM
11 November 2019 02:05
11 11 2019 02:05
Second Price Monitoring Extn
Price Monitoring Extension
PME
11 November 2019 02:00
11 11 2019 02:00
Price Monitoring Extension
Update in relation to loan facility
MSC
11 November 2019 07:00
11 11 2019 07:00
Update in relation to loan facility
Holding(s) in Company
HOL
17 October 2019 04:27
17 10 2019 04:27
Holding(s) in Company
Trading Update
TST
17 October 2019 07:00
17 10 2019 07:00
Trading Update
Holding(s) in Company
HOL
15 October 2019 03:27
15 10 2019 03:27
Holding(s) in Company
DermaPure Product Line Extension Launched
NRA
03 October 2019 07:00
03 10 2019 07:00
DermaPure Product Line Extension Launched
Unaudited Interim Results
IR
10 September 2019 07:00
10 09 2019 07:00
Unaudited Interim Results
Appointment of CFO
BOA
28 August 2019 07:00
28 08 2019 07:00
Appointment of CFO
Additional manufacturing capacity secured
MSC
15 August 2019 07:00
15 08 2019 07:00
Additional manufacturing capacity secured
Directorate Change
BOA
01 August 2019 07:00
01 08 2019 07:00
Directorate Change
Holding(s) in Company
HOL
08 July 2019 05:03
08 07 2019 05:03
Holding(s) in Company
Result of AGM
RAG
27 June 2019 10:51
27 06 2019 10:51
Result of AGM
Issue of Equity and Total Voting Rights
IOE
07 June 2019 02:55
07 06 2019 02:55
Issue of Equity and Total Voting Rights
Notice of AGM
NOA
04 June 2019 07:00
04 06 2019 07:00
Notice of AGM
Secures Credit Facilities of up to $20m
MSC
04 June 2019 07:00
04 06 2019 07:00
Secures Credit Facilities of up to $20m
Annual Results for the year ended 31 December 2018
FR
04 June 2019 07:00
04 06 2019 07:00
Annual Results for the year ended 31 December 2018
CEO to return to full time duties
BOA
21 May 2019 07:00
21 05 2019 07:00
CEO to return to full time duties
Expands US GPO coverage for DermaPure
NRA
04 April 2019 07:26
04 04 2019 07:26
Expands US GPO coverage for DermaPure
Change of Adviser
APP
18 February 2019 07:00
18 02 2019 07:00
Change of Adviser
Second Price Monitoring Extn
APM
06 February 2019 11:05
06 02 2019 11:05
Second Price Monitoring Extn
Price Monitoring Extension
PME
06 February 2019 11:00
06 02 2019 11:00
Price Monitoring Extension
Trading Update
TST
04 February 2019 07:00
04 02 2019 07:00
Trading Update
Interim Management Change
BOA
06 December 2018 07:00
06 12 2018 07:00
Interim Management Change
Pan European distribution agreement with Arthrex
CNT
13 November 2018 07:00
13 11 2018 07:00
Pan European distribution agreement with Arthrex
Gareth Jones commences position as CFO
BOA
29 October 2018 07:00
29 10 2018 07:00
Gareth Jones commences position as CFO
Unaudited Interim Results
IR
03 September 2018 07:00
03 09 2018 07:00
Unaudited Interim Results
Notice of Interim Results
NOR
02 August 2018 07:00
02 08 2018 07:00
Notice of Interim Results
Appointment of CFO
BOA
04 July 2018 07:00
04 07 2018 07:00
Appointment of CFO
HTA License granted and UK distribution Agreement
CNT
25 June 2018 07:00
25 06 2018 07:00
HTA License granted and UK distribution Agreement
Issue of Equity
IOE
18 June 2018 07:00
18 06 2018 07:00
Issue of Equity
Result of AGM
RAG
24 May 2018 12:12
24 05 2018 12:12
Result of AGM
TRX BioSurgery GPO agreement with Premier, Inc.
CNT
02 May 2018 07:00
02 05 2018 07:00
TRX BioSurgery GPO agreement with Premier, Inc.
Posting of Annual Report and Notice of AGM
NOA
27 April 2018 07:00
27 04 2018 07:00
Posting of Annual Report and Notice of AGM
DermaPure manufacturing at CellRight Facility
MSC
24 April 2018 07:00
24 04 2018 07:00
DermaPure manufacturing at CellRight Facility
Holding(s) in Company
HOL
19 April 2018 03:29
19 04 2018 03:29
Holding(s) in Company
Annual results for period ended 31 December 2017
FR
26 March 2018 07:00
26 03 2018 07:00
Annual results for period ended 31 December 2017
Publication of Financial Results
NOR
16 March 2018 03:40
16 03 2018 03:40
Publication of Financial Results
Long term distribution agreement with Arthrex, Inc
CNT
06 March 2018 07:00
06 03 2018 07:00
Long term distribution agreement with Arthrex, Inc
Launch of BioSurgery and new distributor agreement
CNT
26 February 2018 07:00
26 02 2018 07:00
Launch of BioSurgery and new distributor agreement
Notice of Results
NOR
26 February 2018 07:00
26 02 2018 07:00
Notice of Results
Issue of Equity
MSC
02 February 2018 07:00
02 02 2018 07:00
Issue of Equity
Issue of Equity
IOE
22 December 2017 09:30
22 12 2017 09:30
Issue of Equity
Directorate Change
BOA
01 December 2017 07:00
01 12 2017 07:00
Directorate Change
Issue of Equity
IOE
01 December 2017 07:00
01 12 2017 07:00
Issue of Equity
Appointment of CEO
BOA
02 November 2017 07:00
02 11 2017 07:00
Appointment of CEO
Directorate Change
BOA
18 October 2017 07:00
18 10 2017 07:00
Directorate Change
Unaudited Interim Results
IR
28 September 2017 03:15
28 09 2017 03:15
Unaudited Interim Results
Notice of Results
NOR
08 September 2017 07:00
08 09 2017 07:00
Notice of Results
Notification Of Major Holdings
HOL
05 September 2017 03:52
05 09 2017 03:52
Notification Of Major Holdings
Issue of Equity
IOE
30 August 2017 05:15
30 08 2017 05:15
Issue of Equity
Holding(s) in Company
HOL
16 August 2017 12:22
16 08 2017 12:22
Holding(s) in Company
Holding(s) in Company
HOL
11 August 2017 03:45
11 08 2017 03:45
Holding(s) in Company
Holding(s) in Company
HOL
11 August 2017 03:37
11 08 2017 03:37
Holding(s) in Company
Holding(s) in Company
HOL
10 August 2017 04:30
10 08 2017 04:30
Holding(s) in Company
Holding(s) in Company
HOL
10 August 2017 02:45
10 08 2017 02:45
Holding(s) in Company
Holding(s) in Company
HOL
10 August 2017 10:10
10 08 2017 10:10
Holding(s) in Company
Holding(s) in Company
HOL
09 August 2017 03:00
09 08 2017 03:00
Holding(s) in Company
Director/PDMR Shareholding
DSH
09 August 2017 02:30
09 08 2017 02:30
Director/PDMR Shareholding
Results of General Meeting and Total Voting Rights
N/A
08 August 2017 01:41
08 08 2017 01:41
Results of General Meeting and Total Voting Rights
Circ re.CellRight Acquisition
N/A
21 July 2017 06:00
21 07 2017 06:00
Circ re.CellRight Acquisition
Successful fundraising of £40 million
ROI
21 July 2017 08:05
21 07 2017 08:05
Successful fundraising of £40 million
Proposed Acquisition and Placing
ACQ
20 July 2017 06:03
20 07 2017 06:03
Proposed Acquisition and Placing
Result of AGM
RAG
30 June 2017 12:00
30 06 2017 12:00
Result of AGM
Annual results for period ended 31 December 2016
FR
02 June 2017 07:00
02 06 2017 07:00
Annual results for period ended 31 December 2016
Potential Acquisition Update
ACQ
31 May 2017 10:46
31 05 2017 10:46
Potential Acquisition Update
Potential Acquisition
ACQ
19 May 2017 11:35
19 05 2017 11:35
Potential Acquisition
Issue of Equity
IOE
03 April 2017 07:00
03 04 2017 07:00
Issue of Equity
Innovative Technology Contract Awarded
CNT
01 March 2017 07:00
01 03 2017 07:00
Innovative Technology Contract Awarded
DermaPure® added to the Federal Supply Schedule
CNT
02 February 2017 07:00
02 02 2017 07:00
DermaPure® added to the Federal Supply Schedule
Directorate Change
BOA
06 January 2017 07:00
06 01 2017 07:00
Directorate Change
TR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
HOL
07 December 2016 01:04
07 12 2016 01:04
TR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
DermaPure secures GPO agreement with Premier, Inc.
CNT
06 December 2016 07:00
06 12 2016 07:00
DermaPure secures GPO agreement with Premier, Inc.
OrthoPureT XT update
N/A
28 November 2016 07:05
28 11 2016 07:05
OrthoPureT XT update
Directorate Change
BOA
22 November 2016 07:00
22 11 2016 07:00
Directorate Change
Interim Results
IR
12 October 2016 07:00
12 10 2016 07:00
Interim Results
Notice of Interim Results
NOR
28 September 2016 07:00
28 09 2016 07:00
Notice of Interim Results
DermaPure® Medicare coverage in further 10 States
N/A
01 September 2016 07:00
01 09 2016 07:00
DermaPure® Medicare coverage in further 10 States
TR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
HOL
18 July 2016 11:20
18 07 2016 11:20
TR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
Orthopaedics Update
MSC
11 July 2016 07:00
11 07 2016 07:00
Orthopaedics Update
Result of AGM
RAG
04 July 2016 10:41
04 07 2016 10:41
Result of AGM
DermaPure® secures first GPO contract in US
CNT
01 July 2016 07:00
01 07 2016 07:00
DermaPure® secures first GPO contract in US
Deferred Annual Bonus Scheme
DSH
30 June 2016 07:00
30 06 2016 07:00
Deferred Annual Bonus Scheme
New appointment adds clinical expertise to Board
BOA
01 June 2016 07:00
01 06 2016 07:00
New appointment adds clinical expertise to Board
Preliminary results for year ended 31 January 2016
FR
23 May 2016 07:00
23 05 2016 07:00
Preliminary results for year ended 31 January 2016
Notice of Preliminary Results
NOR
20 April 2016 07:00
20 04 2016 07:00
Notice of Preliminary Results
Change of Registered Office
CRO
14 April 2016 07:00
14 04 2016 07:00
Change of Registered Office
Second Price Monitoring Extn
APM
24 March 2016 04:40
24 03 2016 04:40
Second Price Monitoring Extn
Price Monitoring Extension
PME
24 March 2016 04:35
24 03 2016 04:35
Price Monitoring Extension
TR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
HOL
11 March 2016 03:02
11 03 2016 03:02
TR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
Further Medicare Coverage for DermaPure®
N/A
09 March 2016 07:00
09 03 2016 07:00
Further Medicare Coverage for DermaPure®
510k market clearance granted for SurgiPureT XD
N/A
09 March 2016 07:00
09 03 2016 07:00
510k market clearance granted for SurgiPureT XD
Joint Venture Agreement
MSC
26 January 2016 12:21
26 01 2016 12:21
Joint Venture Agreement
Appointment of Non-Executive Director
BOA
19 January 2016 07:00
19 01 2016 07:00
Appointment of Non-Executive Director
OrthoPureT XM clinical trial enrolment completed
MSC
18 January 2016 07:00
18 01 2016 07:00
OrthoPureT XM clinical trial enrolment completed
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
HOL
23 December 2015 12:40
23 12 2015 12:40
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
OrthoPureT XT implants successfully undertaken
MSC
04 December 2015 07:00
04 12 2015 07:00
OrthoPureT XT implants successfully undertaken
Issue of equity and total voting rights
MSC
05 November 2015 04:42
05 11 2015 04:42
Issue of equity and total voting rights
Issue of equity and total voting rights
MSC
26 October 2015 07:00
26 10 2015 07:00
Issue of equity and total voting rights
Non-Executive Director Share Purchase
DSH
23 October 2015 07:49
23 10 2015 07:49
Non-Executive Director Share Purchase
Interim Results
IR
12 October 2015 07:00
12 10 2015 07:00
Interim Results
Notice of Interim Results and Capital Markets Day
MSC
04 September 2015 10:11
04 09 2015 10:11
Notice of Interim Results and Capital Markets Day
Further Medicare Coverage Approval for DermaPure
N/A
30 July 2015 07:00
30 07 2015 07:00
Further Medicare Coverage Approval for DermaPure
Additional US regional distribution agreement
AGR
22 July 2015 07:00
22 07 2015 07:00
Additional US regional distribution agreement
Further Medicare Coverage Approval for DermaPure®
MSC
26 June 2015 07:00
26 06 2015 07:00
Further Medicare Coverage Approval for DermaPure®
Result of AGM
RAG
12 June 2015 12:43
12 06 2015 12:43
Result of AGM
Holding(s) in Company
HOL
21 May 2015 09:51
21 05 2015 09:51
Holding(s) in Company
Employee SAYE Share Plan
MSC
20 May 2015 07:00
20 05 2015 07:00
Employee SAYE Share Plan
Deferred Annual Bonus Award
MSC
12 May 2015 07:00
12 05 2015 07:00
Deferred Annual Bonus Award
Final Results
FR
11 May 2015 07:00
11 05 2015 07:00
Final Results
Further Medicare Coverage Approval for DermaPure
MSC
11 May 2015 07:00
11 05 2015 07:00
Further Medicare Coverage Approval for DermaPure
US regional distribution agreement signed
MSC
05 May 2015 07:02
05 05 2015 07:02
US regional distribution agreement signed
Holding(s) in Company
HOL
01 May 2015 04:01
01 05 2015 04:01
Holding(s) in Company
Notice of Preliminary Results
NOR
09 March 2015 02:05
09 03 2015 02:05
Notice of Preliminary Results
DermaPure gains Medicare coverage approval
MSC
06 March 2015 07:09
06 03 2015 07:09
DermaPure gains Medicare coverage approval
Issue of equity and total voting rights
MSC
05 March 2015 01:36
05 03 2015 01:36
Issue of equity and total voting rights
Resignation of Dr Alison Fielding
MSC
26 February 2015 10:43
26 02 2015 10:43
Resignation of Dr Alison Fielding
Result of General Meeting
ROM
09 February 2015 12:05
09 02 2015 12:05
Result of General Meeting
Issue of equity and total voting rights
MSC
04 February 2015 10:59
04 02 2015 10:59
Issue of equity and total voting rights
Results of Placing
MSC
22 January 2015 11:13
22 01 2015 11:13
Results of Placing
Proposed placing of new Ordinary Shares
MSC
22 January 2015 07:00
22 01 2015 07:00
Proposed placing of new Ordinary Shares
Holding(s) in Company
HOL
01 December 2014 09:45
01 12 2014 09:45
Holding(s) in Company
Holding(s) in Company
HOL
28 November 2014 09:45
28 11 2014 09:45
Holding(s) in Company
Tissue Regenix gains Medicare and Medicaid Q code
MSC
05 November 2014 07:00
05 11 2014 07:00
Tissue Regenix gains Medicare and Medicaid Q code
Interim Results
IR
29 October 2014 07:00
29 10 2014 07:00
Interim Results
Interim Results and Capital Markets Day
NOR
22 October 2014 09:01
22 10 2014 09:01
Interim Results and Capital Markets Day
Initial Clinical Trial Results
MSC
17 October 2014 03:35
17 10 2014 03:35
Initial Clinical Trial Results
UK meniscus clinical trial & DermaPure US updates
MSC
30 July 2014 07:00
30 07 2014 07:00
UK meniscus clinical trial & DermaPure US updates
Issue of equity and total voting rights
IOE
18 July 2014 11:11
18 07 2014 11:11
Issue of equity and total voting rights
Result of AGM
RAG
27 June 2014 03:06
27 06 2014 03:06
Result of AGM
Holding(s) in Company
HOL
12 June 2014 03:46
12 06 2014 03:46
Holding(s) in Company
Tissue Regenix announces launch of DermaPure in US
MSC
12 June 2014 07:00
12 06 2014 07:00
Tissue Regenix announces launch of DermaPure in US
Preliminary Decision to Approve "Q" Code Request
MSC
22 May 2014 07:00
22 05 2014 07:00
Preliminary Decision to Approve "Q" Code Request
Deferred Annual Bonus Award
MSC
20 May 2014 07:00
20 05 2014 07:00
Deferred Annual Bonus Award
Annual Report & Accounts and Notice of AGM
N/A
19 May 2014 10:21
19 05 2014 10:21
Annual Report & Accounts and Notice of AGM
Preliminary results for year ended 31 January 2014
FR
19 May 2014 07:00
19 05 2014 07:00
Preliminary results for year ended 31 January 2014
Notice of Preliminary Results
NOR
12 May 2014 11:00
12 05 2014 11:00
Notice of Preliminary Results
Holding(s) in Company
HOL
30 April 2014 05:14
30 04 2014 05:14
Holding(s) in Company
Holding(s) in Company
HOL
24 April 2014 08:40
24 04 2014 08:40
Holding(s) in Company
Issue of Share Options
DSH
04 February 2014 03:03
04 02 2014 03:03
Issue of Share Options
Holding(s) in Company
HOL
31 January 2014 01:11
31 01 2014 01:11
Holding(s) in Company
Issue of equity and total voting rights
IOE
14 January 2014 05:22
14 01 2014 05:22
Issue of equity and total voting rights
Issue of equity and total voting rights
IOE
09 January 2014 11:11
09 01 2014 11:11
Issue of equity and total voting rights
Tissue Regenix signs US distribution agreements
AGR
12 December 2013 07:00
12 12 2013 07:00
Tissue Regenix signs US distribution agreements
Director Share Purchase
DSH
22 November 2013 07:00
22 11 2013 07:00
Director Share Purchase
Presentation at Proactiveinvestors Forum in Dublin
MSC
29 October 2013 07:00
29 10 2013 07:00
Presentation at Proactiveinvestors Forum in Dublin
Director Share Purchase
DSH
28 October 2013 04:49
28 10 2013 04:49
Director Share Purchase
Holding(s) in Company
HOL
17 October 2013 04:41
17 10 2013 04:41
Holding(s) in Company
Holding(s) in Company
HOL
17 October 2013 04:41
17 10 2013 04:41
Holding(s) in Company
Holding(s) in Company
HOL
17 October 2013 04:41
17 10 2013 04:41
Holding(s) in Company
Interim Results for six months ended 31 July 2013
IR
08 October 2013 07:00
08 10 2013 07:00
Interim Results for six months ended 31 July 2013
Holding(s) in Company
HOL
06 August 2013 09:41
06 08 2013 09:41
Holding(s) in Company
Holding(s) in Company
HOL
25 July 2013 04:59
25 07 2013 04:59
Holding(s) in Company
Appointment of Non-Executive Director
BOA
17 July 2013 07:00
17 07 2013 07:00
Appointment of Non-Executive Director
Appointment of Non-Executive Director
BOA
10 July 2013 07:00
10 07 2013 07:00
Appointment of Non-Executive Director
Tissue Regenix advances US commercialisation
MSC
18 June 2013 07:00
18 06 2013 07:00
Tissue Regenix advances US commercialisation
Result of AGM
RAG
14 June 2013 12:43
14 06 2013 12:43
Result of AGM
Annual Report and Notice of AGM
NOA
14 May 2013 03:47
14 05 2013 03:47
Annual Report and Notice of AGM
Preliminary results for the year ended 31 Jan 2013
FR
13 May 2013 07:00
13 05 2013 07:00
Preliminary results for the year ended 31 Jan 2013
Notice of Results
NOR
03 May 2013 07:00
03 05 2013 07:00
Notice of Results
Results of dCELL Dermis trial
MSC
02 May 2013 07:00
02 05 2013 07:00
Results of dCELL Dermis trial
Change of Nominated Adviser and Broker
APP
29 April 2013 07:00
29 04 2013 07:00
Change of Nominated Adviser and Broker
Approval for start of clinical research trial
MSC
16 April 2013 07:00
16 04 2013 07:00
Approval for start of clinical research trial
Director Change
BOA
11 March 2013 07:00
11 03 2013 07:00
Director Change
Holding(s) in Company
HOL
15 February 2013 02:38
15 02 2013 02:38
Holding(s) in Company
Successful safety study of dCELL® Meniscus
MSC
14 February 2013 07:00
14 02 2013 07:00
Successful safety study of dCELL® Meniscus
Directorate Change
BOA
11 February 2013 02:57
11 02 2013 02:57
Directorate Change
Holding(s) in Company
HOL
09 January 2013 07:15
09 01 2013 07:15
Holding(s) in Company
Tissue Regenix board changes
BOA
30 November 2012 11:21
30 11 2012 11:21
Tissue Regenix board changes
Interim data from clinical trial of dCELL® Dermis
MSC
04 October 2012 07:00
04 10 2012 07:00
Interim data from clinical trial of dCELL® Dermis
Half Yearly Report
IR
04 October 2012 07:00
04 10 2012 07:00
Half Yearly Report
Notice of Results
NOR
28 September 2012 03:30
28 09 2012 03:30
Notice of Results
dCELL(R) vascular patch is safe and effective
RES
07 September 2012 07:00
07 09 2012 07:00
dCELL(R) vascular patch is safe and effective
Director/PDMR Shareholding
DSH
31 July 2012 03:02
31 07 2012 03:02
Director/PDMR Shareholding
Holding(s) in Company
HOL
19 June 2012 02:39
19 06 2012 02:39
Holding(s) in Company
Result of AGM
RAG
11 June 2012 12:35
11 06 2012 12:35
Result of AGM
Expands scope of development activities with NHSBT
MSC
25 May 2012 07:00
25 05 2012 07:00
Expands scope of development activities with NHSBT
Final Results
FR
10 May 2012 07:00
10 05 2012 07:00
Final Results
Poster shown at SAWC
MSC
19 April 2012 01:49
19 04 2012 01:49
Poster shown at SAWC
Notice of Results
NOR
16 April 2012 03:18
16 04 2012 03:18
Notice of Results
Issue of Equity and Total Voting Rights
IOE
07 February 2012 04:00
07 02 2012 04:00
Issue of Equity and Total Voting Rights
Holding(s) in Company
HOL
11 January 2012 11:36
11 01 2012 11:36
Holding(s) in Company
Holding(s) in Company
HOL
06 January 2012 05:05
06 01 2012 05:05
Holding(s) in Company
Holding(s) in Company
HOL
03 January 2012 05:45
03 01 2012 05:45
Holding(s) in Company
Holding(s) in Company
HOL
03 January 2012 05:43
03 01 2012 05:43
Holding(s) in Company
Holding(s) in Company
HOL
03 January 2012 08:49
03 01 2012 08:49
Holding(s) in Company
Result of General Meeting
ROM
28 December 2011 12:00
28 12 2011 12:00
Result of General Meeting
Issue of Equity
IOE
08 December 2011 12:53
08 12 2011 12:53
Issue of Equity
Holding(s) in Company
HOL
04 November 2011 02:16
04 11 2011 02:16
Holding(s) in Company
Holding(s) in Company
HOL
14 October 2011 02:33
14 10 2011 02:33
Holding(s) in Company
Half Yearly Report
IR
10 October 2011 07:00
10 10 2011 07:00
Half Yearly Report
Issue of Equity
IOE
26 July 2011 11:04
26 07 2011 11:04
Issue of Equity
Issue of Share Options
IOE
07 July 2011 03:52
07 07 2011 03:52
Issue of Share Options
Issue of Equity
IOE
05 July 2011 01:30
05 07 2011 01:30
Issue of Equity
Receives EUR280,000 Grant Funding
MSC
22 June 2011 08:35
22 06 2011 08:35
Receives EUR280,000 Grant Funding
Directorate Appointment
BOA
13 June 2011 07:00
13 06 2011 07:00
Directorate Appointment
AGM Statement
AGM
03 June 2011 10:02
03 06 2011 10:02
AGM Statement
Positive Results in Clinical Evaluation of dCELL
MSC
11 May 2011 07:00
11 05 2011 07:00
Positive Results in Clinical Evaluation of dCELL
Final Results
FR
04 May 2011 07:00
04 05 2011 07:00
Final Results
Tissue Regenix enters commercialisation agreement
AGR
21 April 2011 07:00
21 04 2011 07:00
Tissue Regenix enters commercialisation agreement
Directorate Change
BOA
29 March 2011 07:00
29 03 2011 07:00
Directorate Change
Notice of allowance of patent received
MSC
10 March 2011 07:00
10 03 2011 07:00
Notice of allowance of patent received
Holding(s) in Company
HOL
04 January 2011 11:27
04 01 2011 11:27
Holding(s) in Company
Holding(s) in Company
HOL
30 December 2010 09:05
30 12 2010 09:05
Holding(s) in Company
Change of Adviser
APP
23 December 2010 12:44
23 12 2010 12:44
Change of Adviser
Adviser - Change of Name
MSC
21 December 2010 10:12
21 12 2010 10:12
Adviser - Change of Name
Research Update
RES
16 December 2010 07:00
16 12 2010 07:00
Research Update
Change of Adviser
APP
10 December 2010 09:20
10 12 2010 09:20
Change of Adviser
Total Voting Rights
TVR
30 November 2010 03:48
30 11 2010 03:48
Total Voting Rights
Change of Registered Office
CRO
26 November 2010 03:12
26 11 2010 03:12
Change of Registered Office
Issue of Equity
IOE
23 November 2010 05:18
23 11 2010 05:18
Issue of Equity
Half Yearly Report
IR
20 October 2010 07:00
20 10 2010 07:00
Half Yearly Report
Holding(s) in Company
HOL
18 August 2010 02:19
18 08 2010 02:19
Holding(s) in Company
CE Mark Grant
N/A
10 August 2010 07:00
10 08 2010 07:00
CE Mark Grant
Holding(s) in Company
N/A
01 July 2010 10:38
01 07 2010 10:38
Holding(s) in Company
Tissue Regenix Group - Issue of Equity
N/A
29 June 2010 04:37
29 06 2010 04:37
Tissue Regenix Group - Issue of Equity
Tissue Regenix Group - First Day of Dealings
N/A
29 June 2010 07:00
29 06 2010 07:00
Tissue Regenix Group - First Day of Dealings
«
‹
x
›
»
